The following information is intended for healthcare professionals
Supporting insulin-dependent diabetic patients
Wockhardt UK has been committed to the provision
of porcine and bovine insulins for many years, recognising
the medical needs and preferences of each individual person with
Novo Nordisk's porcine insulin range has now been withdrawn.
The Department of Health fully accepts that some people are better suited to porcine or bovine insulin and that these insulins should continue to be made available. Because Wockhardt UK firmly believes in maintaining freedom of choice for those needing insulin, we can reassure you that:
Hypurin® porcine and bovine insulin will continue to be available for the foreseeable future.
Wockhardt UK also produces Glibenclamide, Gliclazide and Metformin tablets.
For a full Diabetes product listing, please select
the Diabetes Therapy Area within the Product Search function.